Coya Therapeutics, Inc.
USD5.50
+0.37 (+7.21%)
CEO
Arun Swaminathan
IPO Date
2022-12-29
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.20
Prev. Close
$5.13
Day Low
$5.00
Day High
$5.50
52W Low
$3.71
52W High
$7.75
Market Cap
$0.10B
Volume
0.23M
| $0.00 |
| 26 Jan 2026 | SNYDER DAVID S | Chief Financial Officer | A-Award | Acquired | 140,041 | $4.73 |
| 26 Jan 2026 | Grossman Fred | Chief Medical Officer | A-Award | Acquired | 140,041 | $4.73 |
| 26 Jan 2026 | Berman Howard | director, officer: Executive Chairman | A-Award | Acquired | 15,257 | $4.73 |
| 26 Jan 2026 | Swaminathan Arun | director, officer: Chief Executive Officer | A-Award | Acquired | 293,983 | $4.73 |
| 6 Jan 2026 | Villalobos Anabella | director | A-Award | Acquired | 10,000 | $5.65 |
| 6 Jan 2026 | GOLDSTEIN DOV A MD | director | A-Award | Acquired | 10,000 | $5.65 |
| 6 Jan 2026 | Weinand Dieter | director | A-Award | Acquired | 10,000 | $5.65 |
| 6 Jan 2026 | ROSS WILBUR L JR | director | A-Award | Acquired | 10,000 | $5.65 |